Marked dissociation between high noradrenaline versus low noradrenaline transporter levels in human nucleus accumbens

Journal of Neurochemistry

Volumn 102, Issue 5, 2007, Pages 1691-1702

  Tong, Junchao ^a   Hornykiewicz, Oleh ^b   Furukawa, Yoshiaki ^a   Kish, Stephen J ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b Medical University of Vienna   (Austria)

Author keywords

Dopamine hydroxylase; Noradrenaline; Nucleus accumbens; Postmortem human brain; Serotonin; Transporter

Indexed keywords

BRAIN MONOAMINE; BRAIN PROTEIN; DOPAMINE BETA MONOOXYGENASE; NEUROTRANSMITTER; NORADRENALIN; NORADRENALIN TRANSPORTER; SEROTONIN; SEROTONIN TRANSPORTER;

ADOLESCENT; ADULT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DISSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOBLOTTING; MALE; NORADRENALIN BRAIN LEVEL; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL;

ADULT; DOPAMINE; DOPAMINE BETA-HYDROXYLASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; NUCLEUS ACCUMBENS; POSTMORTEM CHANGES; SEROTONIN; STATISTICS AS TOPIC; TISSUE DISTRIBUTION;

EID: 34547859639     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04636.x     Document Type: Article

References (62)

1. Ando K., Miyata H. Yanagita T. (1994) Effects of methamphetamine, dopamine and noradrenaline administered into the nucleus accumbens of rats discriminating subcutaneous methamphetamine. Jpn. J. Pharmacol. 64, 35 40.
2. Andy O. J. Stephan H. (1968) The septum in the human brain. J. Comp. Neurol. 133, 383 410.
3. Aoki C., Venkatesan C., Go C. G., Forman R. Kurose H. (1998) Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons. Cereb. Cortex 8, 269 277.
4. Arai H., Kosaka K. Iizuka R. (1984) Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia. J. Neurochem. 43, 388 393.
5. Callado L. F. Stamford J. A. (2000) Spatiotemporal interaction of alpha(2) autoreceptors and noradrenaline transporters in the rat locus coeruleus: implications for volume transmission. J. Neurochem. 74, 2350 2358.
6. Carboni E., Tanda G. L., Frau R. Di Chiara G. (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 55, 1067 1070.
7. Charnay Y., Leger L., Vallet P. G., Hof P. R., Jouvet M. Bouras C. (1995) [3H]Nisoxetine binding sites in the cat brain: an autoradiographic study. Neuroscience 69, 259 270.
8. Chinaglia G., Alvarez F. J., Probst A. Palacios J. M. (1992) Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol. Neuroscience 49, 317 327.
9. Ciliax B. J., Drash G. W., Staley J. K., Haber S., Mobley C. J., Miller G. W., Mufson E. J., Mash D. C. Levey A. I. (1999) Immunocytochemical localization of the dopamine transporter in human brain. J. Comp. Neurol. 409, 38 56.
10. Costall B., Naylor R. J. Pinder R. M. (1976) Characterisation of the mechanisms for hyperactivity induction from the nucleus accumbens by phenylethylamine derivatives. Psychopharmacology (Berl.) 48, 225 231.
11. Cross A. J., Crow T. J., Killpack W. S., Longden A., Owen F. Riley G. J. (1978) The activities of brain dopamine-beta-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls. Psychopharmacology (Berl.) 59, 117 121.
12. Delfs J. M., Zhu Y., Druhan J. P. Aston-Jones G. S. (1998) Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat. Brain Res. 806, 127 140.
13. Delfs J. M., Zhu Y., Druhan J. P. Aston-Jones G. (2000) Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403, 430 434.
14. Ding Y. S, Lin K. S. Logan J. (2006) PET imaging of norepinephrine transporters. Curr. Pharm. Des. 12, 3831 3845.
15. Donnan G. A., Kaczmarczyk S. J., Paxinos G., Chilco P. J., Kalnins R. M., Woodhouse D. G. Mendelsohn F. A. (1991) Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H]mazindol autoradiography. J. Comp. Neurol. 304, 419 434.
16. Epstein J., Pan H., Kocsis J. H. et al. (2006) Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. Am. J. Psychiatry 163, 1784 1790.
17. Farley I. J. Hornykiewicz O. (1977) Noradrenaline distribution in subcortical areas of the human brain. Brain Res. 126, 53 62.
18. Farley I. J., Price K. S., McCullough E., Deck J. H., Hordynski W. Hornykiewicz O. (1978) Norepinephrine in chronic paranoid schizophrenia: above-normal levels in limbic forebrain. Science 200, 456 458.
19. Gaspar P., Berger B., Alvarez C., Vigny A. Henry J. P. (1985) Catecholaminergic innervation of the septal area in man: immunocytochemical study using TH and DBH antibodies. J. Comp. Neurol. 241, 12 33.
20. Giros B., Wang Y. M., Suter S., McLeskey S. B., Pifl C. Caron M. G. (1994) Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem. 269, 15985 15988.
21. Gobert A., Billiras R., Cistarelli L. Millan M. J. (2004) Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors. J. Neurosci. Methods 140, 141 152.
22. Gresch P. J., Sved A. F., Zigmond M. J. Finlay J. M. (1995) Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J. Neurochem. 65, 111 1116.
23. Gross-Isseroff R., Israeli M. Biegon A. (1988) Autoradiographic analysis of [3H]desmethylimipramine binding in the human brain postmortem. Brain Res. 456, 120 126.
24. Gu H., Wall S. C. Rudnick G. (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J. Biol. Chem. 269, 7124 7130.
25. Guttman M., Kish S. J. Furukawa Y. (2003) Current concepts in the diagnosis and management of Parkinson's disease. CMAJ 168, 293 301.
26. Heimer L., Alheid G. F., de Olmos J. S., Groenewegen H. J., Haber S. N., Harlan R. E. Zahm D. S. (1997) The accumbens: beyond the core-shell dichotomy. J. Neuropsychiatry Clin. Neurosci. 9, 354 381.
27. Kish S. J., Furukawa Y., Chang L. J., Tong J., Ginovart N., Wilson A., Houle S. Meyer J. H. (2005) Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? Nucl. Med. Biol. 32, 123 128.
28. Li M. Y., Yan Q. S., Coffey L. L. Reith M. E. (1996) Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamine uptake blockers. J. Neurochem. 66, 559 568.
29. Logan J., Ding Y. S., Lin K. S., Pareto D., Fowler J. Biegon A. (2005) Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region. Nucl. Med. Biol. 32, 531 542.
30. Mandela P. Ordway G. A. (2006) The norepinephrine transporter and its regulation. J. Neurochem. 97, 310 333.
31. Mash D. C., Ouyang Q., Qin Y. Pablo J. (2005) Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers. J. Neurosci. Methods 143, 79 85.
32. McKittrick C. R. Abercrombie E. D. (2007) Catecholamine mapping within nucleus accumbens: differences in basal and amphetamine-stimulated efflux of norepinephrine and dopamine in shell and core. J. Neurochem. 100, 1247 1256.
33. Miles P. R., Mundorf M. L. Wightman R. M. (2002) Release and uptake of catecholamines in the bed nucleus of the stria terminalis measured in the mouse brain slice. Synapse 44, 188 197.
34. Miller G. W., Staley J. K., Heilman C. J., Perez J. T., Mash D. C., Rye D. B. Levey A. I. (1997) Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann. Neurol. 41, 530 539.
35. Miner L. H., Schroeter S., Blakely R. D. Sesack S. R. (2003) Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals. J. Comp. Neurol. 466, 478 494.
36. Miner L. H., Jedema H. P., Moore F. W., Blakely R. D., Grace A. A. Sesack S. R. (2006) Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex. J. Neurosci. 26, 1571 1578.
37. Moore R. Y. Bloom F. E. (1979) Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu. Rev. Neurosci. 2, 113 168.
38. Nagatsu T., Kato T., Numata Y. et al. (1977) Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain. Clin. Chim. Acta 75, 221 232.
39. Nagatsu I., Kobayashi K., Fujii T., Komori K., Sekiguchi K., Titani K., Fujita K. Nagatsu T. (1990) Antibodies raised against different oligopeptide segments of human dopamine-beta-hydroxylase. Neurosci. Lett. 120, 141 145.
40. Nirenberg M. J., Chan J., Pohorille A., Vaughan R. A., Uhl G. R., Kuhar M. J. Pickel V. M. (1997) The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J. Neurosci. 17, 6899 6907.
41. Olson V. G., Heusner C. L., Bland R. J., During M. J., Weinshenker D. Palmiter R. D. (2006) Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward. Science 311, 1017 1020.
42. Ordway G. A., Stockmeier C. A., Cason G. W. Klimek V. (1997) Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. J. Neurosci. 17, 1710 1719.
43. Pifl C., Hornykiewicz O., Giros B. Caron M. G. (1996) Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter. J. Pharmacol. Exp. Ther. 277, 1437 1443.
44. Pijnenburg A. J., Honig W. M. Van Rossum J. M. (1975) Effects of antagonists upon locomotor stimulation induced by injection of dopamine and noradrenaline into the nucleus accumbens of nialamide-pretreated rats. Psychopharmacologia 41, 175 180.
45. Plaznik A., Danysz W. Kostowski W. (1985) A stimulatory effect of intraaccumbens injections of noradrenaline on the behavior of rats in the forced swim test. Psychopharmacology (Berl.) 87, 119 123.
46. Riley H. A. (1943) An Atlas of the Basal Ganglia, Brain Stem and Spinal Cord. The Williams & Wilkins Company, Baltimore, MD.
47. Roitman M. F., Wheeler R. A. Carelli R. M. (2005) Nucleus accumbens neurons are innately tuned for rewarding and aversive taste stimuli, encode their predictors, and are linked to motor output. Neuron 45, 587 597.
48. Sanchez-Gonzalez M. A., Garcia-Cabezas M. A., Rico B. Cavada C. (2005) The primate thalamus is a key target for brain dopamine. J. Neurosci. 25, 6076 6083.
49. Sano I., Gamo T., Kakimoto Y., Taniguchi K., Takesada M. Nishinuma K. (1959) Distribution of catechol compounds in human brain. Biochim. Biophys. Acta 32, 586 587.
50. Schou M., Halldin C., Pike V. W., Mozley P. D., Dobson D., Innis R. B., Farde L. Hall H. (2005) Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2. Eur. Neuropsychopharmacol. 15, 517 520.
51. Schroeter S., Apparsundaram S., Wiley R. G., Miner L. H., Sesack S. R. Blakely R. D. (2000) Immunolocalization of the cocaine- and antidepressant- sensitive l-norepinephrine transporter. J. Comp. Neurol. 420, 211 232.
52. Smith H. R., Beveridge T. J. Porrino L. J. (2006) Distribution of norepinephrine transporters in the non-human primate brain. Neuroscience 138, 703 714.
53. Stone E. A., Lin Y., Ahsan R. Quartermain D. (2004) Gross mapping of alpha1-adrenoceptors that regulate behavioral activation in the mouse brain. Behav. Brain Res. 152, 167 175.
54. Svensson L. Ahlenius S. (1982) Functional importance of nucleus accumbens noradrenaline in the rat. Acta. Pharmacol. Toxicol. (Copenh.) 50, 22 24.
55. Talley E. M., Rosin D. L., Lee A., Guyenet P. G. Lynch K. R. (1996) Distribution of alpha 2A-adrenergic receptor-like immunoreactivity in the rat central nervous system. J. Comp. Neurol. 372, 111 134.
56. Tong J., Hornykiewicz O. Kish S. J. (2006) Identification of a noradrenaline-rich subdivision of the human nucleus accumbens. J. Neurochem. 96, 349 354.
57. Vizi E. S., Zsilla G., Caron M. G. Kiss J. P. (2004) Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors. J. Neurosci. 24, 7888 7894.
58. Wilson J. M., Nobrega J. N., Carroll M. E., Niznik H. B., Shannak K., Lac S. T., Pristupa Z. B., Dixon L. M. Kish S. J. (1994) Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J. Neurosci. 14, 2966 2979.
59. Wilson J. M., Levey A. I., Rajput A., Ang L., Guttman M., Shannak K., Niznik H. B., Hornykiewicz O., Pifl C. Kish S. J. (1996) Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology 47, 718 726.
60. Wise R. A. (2004) Dopamine, learning and motivation. Nat. Rev. Neurosci. 5, 483 494.
61. Worsley J. N., Moszczynska A., Falardeau P. et al. (2000) Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users. Mol. Psychiatry 5, 664 672.
62. Yamamoto B. K. Novotney S. (1998) Regulation of extracellular dopamine by the norepinephrine transporter. J. Neurochem. 71, 274 280.